Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

ECT-12003 (S-CITALOPRAM OXALATE)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

90 API Suppliers, 33 USDMF, 19 CEP/COS, 11 JDMF, 20 EU WC, 30 KDMF, 19 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

546 FDF Dossiers, 80 FDA Orange Book, 221 Europe, 52 Canada, 72 Australia, 41 South Africa, 80 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE, SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 18 SPI Pharma, 7 DKSH, 6 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 21 BASF, 2 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Fillers, Diluents & Binders, 50 Coating Systems & Additives, 31 Thickeners and Stabilizers, 29 Controlled & Modified Release, 28 Solubilizers, 28 Direct Compression, 24 Film Formers & Plasticizers, 22 Disintegrants & Superdisintegrants, 22 Granulation, 21 Parenteral, 19 Taste Masking, 18 Co-Processed Excipients, 18 Topical, 17 Chewable & Orodispersible Aids, 13 Lubricants & Glidants, 11 Rheology Modifiers, 8 Emulsifying Agents, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 128 Regulatory FDF Prices, 13 Annual Reports

MARKET PLACE

14 APIs, 2 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

4 US Exclusivities

4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 4 USP, 3 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Virupaksha Organics	India	M/s Virupaksha Organics Ltd	WC-0191	Escitalopram Oxalate USP	2022-09-16	2025-07-02	Sy No.1 0, Goddapotharam (V), Jinnaram (M), Sangareddy District-502319, Telangana State India
04/06/2025	Neuland Laboratories	India	M/s Neuland Laboratories Ltd	WC-0036	Escitalopram Oxalate IH/USP	2022-06-07	2025-06-16	Unit-I, Sy. No. 347, 473, 474, 490/2, Bonthapally Village, Veerabhadraswamy Temple Road, Gummadidala Mandal, Sangareddy District-502 313, Telangana State, India

ECT-12003 (S-CITALOPRAM OXALATE)

ECT-12003 (S-CITALOPRAM OXALATE)

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

90 API Suppliers

33 USDMF

19 CEP/COS

11 JDMF

20 EU WC

30 KDMF

19 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

546 FDF Dossiers

80 FDA Orange Book

221 Europe

52 Canada

72 Australia

41 South Africa

80 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 20MG BASE

TABLET;ORAL - EQ 5MG BASE

SOLUTION;ORAL - EQ 5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Rochem International Inc

18 SPI Pharma

7 DKSH

6 Faran Shimi Pharmaceutical

2 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 ACG Worldwide

9 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

21 BASF

2 Clariant

10 Corel Pharma Chem

5 DFE Pharma

2 Finar

10 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

31 Kerry

4 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

27 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

3 Silverline Chemicals

3 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

SOLUTION;ORAL - EQ 5MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons